Abstract
X-linked juvenile retinoschisis (XLRS) is a neurodevelopmental abnormality caused by retinoschisin gene mutations. XLRS is characterized by splitting through the retinal layers and impaired synaptic transmission of visual signals resulting in impaired acuity and a propensity to retinal detachment. Several groups have treated murine retinoschisis models successfully using adeno-associated virus (AAV) vectors. Owing to the fragile nature of XLRS retina, translating this therapy to the clinic may require an alternative to invasive subretinal vector administration. Here we show that all layers of the retinoschisin knockout (Rs1-KO) mouse retina can be transduced efficiently with AAV vectors administered by simple vitreous injection. Retinoschisin expression was restricted to the neuroretina using a new vector that uses a 3.5-kb human retinoschisin promoter and an AAV type 8 capsid. Intravitreal administration to Rs1-KO mice resulted in robust retinoschisin expression with a retinal distribution similar to that observed in wild-type retina, including the expression by the photoreceptors lying deep in the retina. No off-target expression was observed. Rs1-KO mice treated with this vector showed a decrease in the schisis cavities and had improved retinal signaling evaluated by recording the electroretinogram 11–15 weeks after the application.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D . X-linked retinoschisis: an update. J Med Genet 2007; 44: 225–232.
Tantri A, Vrabec TR, Cu-Unjieng A, Frost A, Annesley Jr WH, Donoso LA . X-linked retinoschisis: a clinical and molecular genetic review. Surv Ophthalmol 2004; 49: 214–230.
Prenner JL, Capone Jr A, Ciaccia S, Takada Y, Sieving PA, Trese MT . Congenital X-linked retinoschisis classification system. Retina 2006; 26 (7 Suppl): S61–S64.
Minami Y, Ishiko S, Takai Y, Kato Y, Kagokawa H, Takamiya A et al. Retinal changes in juvenile X linked retinoschisis using three dimensional optical coherence tomography. Br J Ophthalmol 2005; 89: 1663–1664.
Peachey NS, Fishman GA, Derlacki DJ, Brigell MG . Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol 1987; 105: 513–516.
George ND, Yates JR, Moore AT . X linked retinoschisis. Br J Ophthalmol 1995; 79: 697–702.
Roesch MT, Ewing CC, Gibson AE, Weber BH . The natural history of X-linked retinoschisis. Can J Ophthalmol 1998; 33: 149–158.
Sasaki K, Ideta H, Yonemoto J, Tanaka S, Hirose A, Oka C . Epidemiologic characterstics of rhegmatogenous retinal detachement in Kumamoto, Japan. Graefes Arch Clin Exp Ophthalmol 1995; 233: 772–776.
Kellner U, Brümmer S, Foerster MH, Wessing A . X-linked congenital retinoschisis. Graefes Arch Clin Exp Ophthalmol 1990; 228: 432–437.
Regillo CD, Tasman WS, Brown GC . Surgical management of complications associated with X-linked retinoschisis. Arch Ophthalmol 1993; 111: 1080–1086.
Rosenfeld PJ, Flynn Jr HW, McDonald HR, Rubsamen PE, Smiddy WE, Sipperley JO et al. Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis. Ophthalmic Surg Lasers 1998; 29: 190–197.
Sauer CG, Gehrig A, Warneke-Wittstock R, Marquardt A, Ewing CC, Gibson A et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet 1997; 17: 164–170.
Takada Y, Fariss RN, Muller M, Bush RA, Rushing EJ, Sieving PA . Retinoschisin expression and localization in rodent and human pineal and consequences of mouse RS1 gene knockout. Mol Vis 2006; 12: 1108–1116.
Baumgartner S, Hofmann K, Chiquet-Ehrismann R, Bucher P . The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci 1998; 7: 1626–1631.
Wu WW, Wong JP, Kast J, Molday RS . RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. J Biol Chem 2005; 280: 10721–10730.
Steiner-Champliaud MF, Sahel J, Hicks D . Retinoschisin forms a multi-molecular complex with extracellular matrix and cytoplasmic proteins: interactions with beta2 laminin and alphaB-crystallin. Mol Vis 2006; 12: 892–901.
Vijayasarathy C, Takada Y, Zeng Y, Bush RA, Sieving PA . Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations. Invest Ophthalmol Vis Sci 2007; 48: 991–1000.
Molday LL, Wu WW, Molday RS . Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex. J Biol Chem 2007; 282: 32792–32801.
Dyka FM, Wu WW, Pfeifer TA, Molday LL, Grigliatti TA, Molday RS . Characterization and purification of the discoidin domain-containing protein retinoschisin and its interaction with galactose. Biochemistry 2008; 47: 9098–9106.
Takada Y, Fariss RN, Tanikawa A, Zeng Y, Carper D, Bush R et al. A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. Invest Ophthalmol Vis Sci 2004; 45: 3302–3312.
Zeng Y, Takada Y, Kjellstrom S, Hiriyanna K, Tanikawa A, Wawrousek E et al. RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Invest Ophthalmol Vis Sci 2004; 45: 3279–3285.
Min SH, Molday LL, Seeliger MW, Dinculescu A, Timmers AM, Janssen A et al. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. Mol Ther 2005; 12: 644–651.
Maguire AM, Simonelli F, Pierce EA, Pugh Jr EN, Mingozzi F, Bennicelli J et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358: 2240–2248.
Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358: 2231–2239.
Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 2008; 105: 15112–15117.
Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM . Novel AAV serotypes for improved ocular gene transfer. J Gene Med 2008; 10: 375–382.
Natkunarajah M, Trittibach P, McIntosh J, Duran Y, Barker SE, Smith AJ et al. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Therapy 2008; 15: 463–467.
Takada Y, Vijayasarathy C, Zeng Y, Kjellstrom S, Bush RA, Sieving PA . Synaptic pathology in retinoschisis knockout (Rs1−/y) mouse retina and modification by rAAV-Rs1 gene delivery. Invest Ophthalmol Vis Sci 2008; 49: 3677–3686.
Kjellstrom S, Bush RA, Zeng Y, Takada Y, Sieving PA . Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. Invest Ophthalmol Vis Sci 2007; 48: 3837–3845.
Bradshaw K, George N, Moore A, Trump D . Mutations of the XLRS1 gene cause abnormalities of photoreceptor as well as inner retinal responses of the ERG. Doc Ophthalmol 1999; 98: 153–173.
Sieving PA, Bingham EL, Kemp L, Richards J, Hiriyanna K . Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave. Am J Ophthalmol 1999; 128: 179–184.
Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 10405–10410.
Walters RW, Agbandje-McKenna M, Bowman VD, Moninger TO, Olson NH, Seiler M et al. Structure of adeno-associated virus serotype 5. J Virol 2004; 78: 3361–3371.
Nam HJ, Lane MD, Padron E, Gurda B, McKenna R, Kohlbrenner E et al. Structure of adeno-associated virus serotype 8, a gene therapy vector. J Virol 2007; 81: 12260–12271.
Gonzalez-Fernandez F . Interphotoreceptor retinoid-binding protein: an old gene for new eyes. Vision Res 2003; 43: 3021–3036.
Grimm D, Zhou S, Nakai H, Thomas CE, Storm TA, Fuess S et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003; 102: 2412–2419.
Acknowledgements
We thank Maria Santos for help with husbandry and Jinbo Li for help with histology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, T., Wu, Z., Kjellstrom, S. et al. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther 16, 916–926 (2009). https://doi.org/10.1038/gt.2009.61
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2009.61
Keywords
This article is cited by
-
Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses
Scientific Reports (2022)
-
AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis
Scientific Reports (2019)
-
Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice
Molecular Therapy - Methods & Clinical Development (2016)